Table 3.

Correlation Between miR-210-3p Expression and Clinicopathological Parameters of Patients with NSCLC (n, %)

Clinical Features	miR-210-3p
	Low Expression	High Expression	p-value
Gender			0.421
Male	16 (57.14%)	12 (42.86%)
Female	10 (45.45%)	12 (54.55%)
Age (median age = 58 years)			0.545
<58	9 (37.50%)	15 (62.50%)
≥58	10 (38.46%)	16 (61.54%)
Smoking			0.061
Non-smoker	6 (46.15%)	7 (53.85%)
Smoker	12 (32.43%)	25 (67.57%)
Clinical stage			0.038
I–II	6 (28.57%)	15 (71.43%)
III	12 (41.38%)	17 (58.62%)
Metastasis (pN)			0.154
N0-N1	13 (44.83%)	16 (55.17%)
N2	8 (38.10%)	13 (61.90%)
Pathological types			0.204
Squamous cell carcinoma	7 (31.82%)	15 (68.18%)
Adenocarcinoma	8 (32.00%)	17 (68.00%)
Others	1 (33.33%)	2 (66.67%)
Organizational rating			0.027
Moderate and high differentiation	14 (41.18%)	20 (58.82%)
Low differentiation	4 (25.00%)	12 (75.00%)